Recurrence of hepatocellular carcinoma at the porta-hepatis following liver transplantation diagnosed on EUS-FNA
- 23 Downloads
Hepatocellular carcinoma (HCC) is a potentially fatal complication of chronic liver disease. Liver transplantation is now the preferred treatment due to good outcomes. We present a unique case of recurrence of HCC at the porta hepatis four years after orthotopic liver transplantation diagnosed via endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). Our report also highlights that intrahepatic recurrence of HCC can be surgically treated. However, further studies are needed to develop treatment algorithms for intra-hepatic recurrence of HCC post liver transplantation.
KeywordsHCC (hepatic cellular carcinoma) Liver transplant EUS (endoscopic ultrasound)
RS, MB, RN prepared the manuscript. SM, SP and PG edited the manuscript and provided expert opinion. SP, PG, SM and RN were involved in the care of this case.
Compliance with ethical standards
Conflict of interest
The authors report no conflict of interest related to this manuscript and no financial declaration.
Informed consent was obtained.
All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Informed consent was obtained from all patients for being included in the study.
- 18.Edoute Y, Ben-Haim SA, Brenner B, et al. Fatal hemoperitoneum after fine-needle aspiration of a liver metastasis. Am J Gastroenterol. 1992;87:358–60.Google Scholar
- 25.Abdo Francis JM. Treatment of non-variceal hemorrhage of the upper digestive tract. Rev Gastroenterol Mex. 1998;63:38–44.Google Scholar
- 26.Ringe B, Böker K, Schlitt HJ, et al. Recurrence of hepatitis B virus cirrhosis and hepatocellular carcinoma: an indication for retransplantation? Clin Transpl. 1995;9:190–6.Google Scholar